BiotechTube
Doron Therapeutics

Doron Therapeutics

San Diego, United States· Est.
dorontherapeutics.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $3.5M

Overview

Doron Therapeutics is a private, pre-revenue biotech founded in 2020, advancing a late-stage biologic for osteoarthritis (OA). The company's core asset, MOTYS™, is a placental tissue-derived biologic positioned as Phase 3-ready, targeting the significant unmet medical need in OA with a proposed mechanism of action combining anti-inflammatory, tissue-protective, and regenerative capabilities. Operating from San Diego, the company is poised to enter pivotal clinical trials, aiming to offer a new therapeutic option for a large and growing patient population with limited disease-modifying treatments.

OsteoarthritisMusculoskeletal

Technology Platform

Placental tissue-derived biologic platform processed for consistent delivery of growth factors and anti-inflammatory proteins for intra-articular administration.

Funding History

1
Total raised:$3.5M
Seed$3.5M

Opportunities

The global osteoarthritis treatment market is large and growing, with a severe lack of approved disease-modifying therapies.
A successful product could achieve blockbuster status.
The intra-articular route offers targeted delivery and may facilitate favorable reimbursement and adoption by orthopedic specialists.

Risk Factors

High risk of Phase 3 clinical trial failure.
Manufacturing complexity for a consistent placental-derived biologic.
Intense competition from other companies developing DMOADs.
The company's valuation is entirely dependent on a single asset.

Competitive Landscape

The competitive landscape for DMOADs is crowded and includes both small molecules and biologics from companies like Biosplice (Lorecivivint), Novartis, and Flexion Therapeutics. MOTYS™ must differentiate itself on efficacy, safety, and durability of effect against both palliative standards of care and other late-stage investigational therapies.

More companies in Biologics / Biosimilars →More companies in United States →